Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Cognitive Function at 3 Years of Age After Fetal Exposure to Antiepileptic Drugs
NEJM 360:1597-1605,1667, Meador,K.J.,et al, 2009
Prenatal Exposure to Antiepileptic Drugs
Lancet 367:1467-1469, Perucca,E. &Tomson,T., 2006
Valproate Therapy and Nonalcoholic Fatty Liver Disease
Ann Neurol 55:729-732, Luef,G.J.,et al, 2004
Valproate Embryopathy in Three Sets of Siblings: Further Proof of Hereditary Susceptibility
Neurol 59:630-633, Malm,H.,et al, 2002
Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000
Protein C Deficiency Related to Valproic Acid Therapy: A Possible Association with Childhood Stroke
J Pediatr 137:714-718, Gruppo,R.,et al, 2000
Antiepileptics and Blood Dyscrasias: A Cohort Study
Pharmacotherapy 18:1277-1283, Blackburn,S.C.F.,et al, 1998
Valproic Acid Hepatic Fatalities. III. U. S. Experience Since 1986
Neurol 46:465-469, Bryant,A.E.&Dreifuss,F., 1996
Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996
Choreiform Movements Associated with the Use of Valproate
Arch Neurol 51:702-704, Lancman,M.E.,et al, 1994
Valproic Acid-Induced Hyperammonemic Encephalopathy:MR Appearance
AJNR 15:1779-1781, Baganz,M.D.&Dross,P.E., 1994
Muscle Carnitine Deficiency in Patients Using Valproic Acid
J Pediatr 118:646-649, Shapira,Y.&Gutman,A., 1991
Valproic Acid-Induced Cytopenias:Evidence for a Dose-Related Suppression of Hematopoiesis
J Pediatr 117:495-497, Watts,R.G.,et al, 1990
Sodium Valproate
Editorial, Lancet 2:1229-12311988., , 1988
Valproic Acid & Secondary Hyperammonemia
Neurol 31:1173-1174, Rawat,S.,et al, 1981